Award

Quick-Med Technologies (QMT) has shown proof of concept for an advanced wound care dressing to speed healing of partial thickness skin wounds in vesicant injured patients, specifically for application after skin debridement. This wound dressing is antimicrobial and superabsorbent to provide moist wound healing while protecting from bacterial infection, including resistant species. The wound dressing speeds healing through continued release of protease inhibitor, a growth factor, and nutritive elements that aid the biochemistry of epithelial regeneration. Phase 2 of this research proposes to optimize release of the active ingredients, test efficacy using a cell culture assay, and move to animal studies with the lead formulation. Evaluation parameters are provided for each step to validate progress.